Guidelines for refilling capmatinib: How to deal with missed doses or vomiting?

Capmatinib, as a targeted drug for MET-mutated non-small cell lung cancer, has brought hope of life to countless patients. However, during the medication process, some unexpected situations, such as missed doses or vomiting, may make patients confused and worried. So, how should patients respond when they encounter these situations?

The drug instructions give clear guidance: If you miss a dose or vomit after taking the medication, it is not recommended to take capmatinib immediately. The most reasonable approach is to wait until the next scheduled dose time before taking it. The advantage of this is to ensure that the concentration of the drug in the body is maintained at a stable and safe level, thereby ensuring the sustainability of the therapeutic effect.

There is science behind such advice. First of all, the metabolism and absorption of capmatinib in the human body follow certain rules. Taking additional medications at unscheduled times may upset this balance, causing excessive accumulation of the medication in the body, thereby increasing the risk of adverse reactions.

Secondly, the dosage and time interval of capmatinib are carefully designed to ensure patient safety and efficacy. Therefore, patients should strictly follow the doctor's recommendations and avoid arbitrary adjustments in dosage or medication time. The standard dosing regimen is 400mg twice daily, with or without food. However, it is important to note that capmatinib tablets should be swallowed whole and should not be crushed, chewed or divided.

If the patient encounters other problems or discomfort during medication, he should contact the attending doctor in time to obtain professional guidance and help. In addition, it is understood that capmatinib is currently sold in overseas markets. The price of original drugs is relatively high, while generic drugs provide a more economical option, with each box selling for about three to four thousand yuan.